These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 23867982)
41. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Paganini-Hill A; Clark LJ Breast Cancer Res Treat; 2000 Nov; 64(2):165-76. PubMed ID: 11194452 [TBL] [Abstract][Full Text] [Related]
42. Estrogen- and tamoxifen-associated effects on brain structure and function. Eberling JL; Wu C; Tong-Turnbeaugh R; Jagust WJ Neuroimage; 2004 Jan; 21(1):364-71. PubMed ID: 14741674 [TBL] [Abstract][Full Text] [Related]
43. Executive functions in men and postmenopausal women. Castonguay N; Lussier M; Bugaiska A; Lord C; Bherer L J Clin Exp Neuropsychol; 2015; 37(2):193-208. PubMed ID: 25695230 [TBL] [Abstract][Full Text] [Related]
44. Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping. Lindner MD; Hogan JB; Hodges DB; Orie AF; Chen P; Corsa JA; Leet JE; Gillman KW; Rose GM; Jones KM; Gribkoff VK Psychopharmacology (Berl); 2006 Nov; 188(4):629-40. PubMed ID: 17004085 [TBL] [Abstract][Full Text] [Related]
45. Decision-making impairments in breast cancer patients treated with tamoxifen. Chen X; Li J; Chen J; Li D; Ye R; Zhang J; Zhu C; Tian Y; Wang K Horm Behav; 2014 Jul; 66(2):449-56. PubMed ID: 25036869 [TBL] [Abstract][Full Text] [Related]
46. Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. Huerta-Ramos E; Iniesta R; Ochoa S; Cobo J; Miquel E; Roca M; Serrano-Blanco A; Teba F; Usall J Eur Neuropsychopharmacol; 2014 Feb; 24(2):223-31. PubMed ID: 24342775 [TBL] [Abstract][Full Text] [Related]
47. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes. Mintzer MZ; Griffiths RR Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344 [TBL] [Abstract][Full Text] [Related]
48. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D; JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113 [TBL] [Abstract][Full Text] [Related]
49. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills. Duka T; Ott H; Rohloff A; Voet B Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876 [TBL] [Abstract][Full Text] [Related]
50. Distinct cognitive effects of estrogen and progesterone in menopausal women. Berent-Spillson A; Briceno E; Pinsky A; Simmen A; Persad CC; Zubieta JK; Smith YR Psychoneuroendocrinology; 2015 Sep; 59():25-36. PubMed ID: 26010861 [TBL] [Abstract][Full Text] [Related]
51. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Dunkin J; Rasgon N; Wagner-Steh K; David S; Altshuler L; Rapkin A Psychoneuroendocrinology; 2005 Apr; 30(3):284-96. PubMed ID: 15511602 [TBL] [Abstract][Full Text] [Related]
52. Cognitive function in postmenopausal women treated with raloxifene. Yaffe K; Krueger K; Sarkar S; Grady D; Barrett-Connor E; Cox DA; Nickelsen T; N Engl J Med; 2001 Apr; 344(16):1207-13. PubMed ID: 11309635 [TBL] [Abstract][Full Text] [Related]
53. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. Schilder CM; Seynaeve C; Beex LV; Boogerd W; Linn SC; Gundy CM; Huizenga HM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB J Clin Oncol; 2010 Mar; 28(8):1294-300. PubMed ID: 20142601 [TBL] [Abstract][Full Text] [Related]
54. Testosterone improves verbal learning and memory in postmenopausal women: Results from a pilot study. Davison SL; Bell RJ; Gavrilescu M; Searle K; Maruff P; Gogos A; Rossell SL; Adams J; Egan GF; Davis SR Maturitas; 2011 Nov; 70(3):307-11. PubMed ID: 21930354 [TBL] [Abstract][Full Text] [Related]
55. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Shaywitz SE; Naftolin F; Zelterman D; Marchione KE; Holahan JM; Palter SF; Shaywitz BA Menopause; 2003; 10(5):420-6. PubMed ID: 14501603 [TBL] [Abstract][Full Text] [Related]
56. Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. Wezenberg E; Verkes RJ; Sabbe BG; Ruigt GS; Hulstijn W Psychopharmacology (Berl); 2005 Sep; 181(3):582-94. PubMed ID: 16041534 [TBL] [Abstract][Full Text] [Related]
57. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Asthana S; Craft S; Baker LD; Raskind MA; Birnbaum RS; Lofgreen CP; Veith RC; Plymate SR Psychoneuroendocrinology; 1999 Aug; 24(6):657-77. PubMed ID: 10399774 [TBL] [Abstract][Full Text] [Related]
58. Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study. Fortin MP; Rouch I; Dauphinot V; Gédéon C; Genthon S; Bonnefoy M; Krolak-Salmon P Drugs Aging; 2011 Mar; 28(3):195-204. PubMed ID: 21329401 [TBL] [Abstract][Full Text] [Related]
59. Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Joshi YB; Thomas ML; Hochberger WC; Bismark AW; Treichler EBH; Molina J; Nungaray J; Cardoso L; Sprock J; Swerdlow NR; Light GA Schizophr Res; 2019 Jun; 208():384-389. PubMed ID: 30738698 [TBL] [Abstract][Full Text] [Related]
60. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens. Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Khaylis A; Rasgon NL Am J Geriatr Psychiatry; 2011 Sep; 19(9):792-802. PubMed ID: 21873835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]